News
Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback